Philip Reigan

Philip Reigan PhD

Associate Professor Computational Chemistry and Biology Core Facility Director
  • Department of Pharmaceutical Sciences

Primary Phone:303-724-6431

Mailing Address:
  • CU Anschutz

Pharmacy and Pharmaceutical Sciences Building

12850 East Montview Boulevard

Lab: V20-2210, 2420E(S)

Office: V20-2102

Aurora, CO 80045

My laboratory studies the design, synthesis and biological evaluation of small-molecule antitumor agents that act on molecular targets associated with the pathology of cancer. Our current research efforts are focused on developing agents for the treatment of brain tumors. The effective treatment of brain tumors presents a number of challenges, the therapeutic agent needs to cross the blood-brain barrier, localize to a specific region of the brain and exhibit tumor selectivity.

Education, Licensure & Certifications

  • Sc, University of Manchester, UK (Chemistry) 
  • MSc, University of Manchester, UK (Pharmacology)
  • PhD, University of Manchester, UK (Medicinal Chemistry) 
  • Postdoctoral Fellow, University of Colorado 
  • MRSC, Member of the Royal Society of Chemistry


  • Member - University of Colorado Cancer Center 
  • Member - Colorado Clinical and Translational Sciences Institute

CMS Login